Quillivant XR 25 MG/5 ML susp 120ML
Ended Awarded
- Contract number
- SPE2DB26FDHC4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,391
Award facts
- Contract value 100% obligated
- $31,391.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,391.19 delivery order to AmerisourceBergen Drug Corp for Quillivant XR 25 mg/5 ml suspension (120 ml) on October 15, 2025, with an ultimate completion date of October 16, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Quillivant XR is a central nervous system stimulant medication used to treat attention-deficit/hyperactivity disorder, representing the type of specialty pharmaceutical product the company routinely delivers through its federal contract portfolio. The DLA Troop Support Medical Supply Chain maintains multiple contractors under its Pharmaceutical Prime Vendor Global Program to ensure comprehensive coverage of pharmaceutical requirements across operational regions.
Quick answers
Who was awarded contract SPE2DB26FDHC4?
SPE2DB26FDHC4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FDHC4 worth?
The government has obligated $31,391 on SPE2DB26FDHC4.
Is contract SPE2DB26FDHC4 an order under another contract?
Yes. SPE2DB26FDHC4 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB26FDHC4 competed?
The extent of competition for SPE2DB26FDHC4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award